Results 131 to 140 of about 8,657 (176)

A comprehensive study on drug-related Raynaud's phenomenon based on the FDA adverse event reporting system. [PDF]

Sci Rep
Zheng P, Zheng X, Chen Q, Wang D, Huang L, Lin J, Chen S.   +6 more
europepmc   +1 more source

Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud's Phenomenon. [PDF]

Pharmaceuticals (Basel)
Screm G, Mondini L, Salton F, Confalonieri P, Bozzi C, Torregiani C, Antonaglia C, Geri P, D'Oria M, Bandini G, Hughes M, Confalonieri M, Ruaro B.   +12 more
europepmc   +1 more source

Digit Amputation Secondary to COVID-19-Induced Raynaud's Phenomenon. [PDF]

Cureus
Carvalho R, Subtil J, Macedo Brás E, Campos J, Silva R.   +4 more
europepmc   +1 more source

Lymphoplasmacytic Lymphoma Presenting as Severe Secondary Raynaud's Phenomenon. [PDF]

Cureus
Rorah DJ, Daghlas S, Badshah M, Schmidt P, Maz M.   +4 more
europepmc   +1 more source

Raynaud's phenomenon associated with psoriatic arthritis. [PDF]

BMJ Case Rep
Che Rahim MJ, Lim JA, Wan Ghazali WS.
europepmc   +1 more source

Paraneoplastic scleroderma: a patient with a history of breast cancer presenting with sclerodactyly and Raynaud's phenomenon. [PDF]

BMJ Case Rep
Phillips EC, Clark MJ, Schirtzinger M.
europepmc   +1 more source

Association between beta-1-adrenoceptor blockade and risk of Raynaud's phenomenon: Mendelian randomisation study. [PDF]

J Scleroderma Relat Disord
Williams JC, Rogers K, Coulson K, Hughes DM, Hughes M, Zhao SS.   +5 more
europepmc   +1 more source

Physical activity, sedentary behaviour and health-related quality of life in 929 women with primary Raynaud's phenomenon. [PDF]

Clin Rheumatol
van de Zande SC, Eijkelenkamp K, Eman Abdulle A, Smit AJ, Zwerver J, van den Akker-Scheek I, Mulder DJ.   +6 more
europepmc   +1 more source